Pasi A. Jänne, MD, PhD, on advances in the treatment of lung cancer at ASCO 2019

Pasi A. Jänne, MD, PhD, on advances in the treatment of lung cancer at ASCO 2019

By |2019-06-11T16:20:09+00:00June 11th, 2019|Accouncements|0 Comments

Dr. Jänne, Director Belfer Center for Applied Cancer Science, presents phase I data for HER3 targeting ADC in patients with EGFR mutant lung cancer patients   at the 2019 ASCO Annual Meeting